(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MMX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MMX

ST13

US500000088820915

Class

5, 44

Filing

88820915

Registration

6481563

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

09/14/2021

Trademark type

Word

Nice classes

5, 44

Filing date

03/04/2020

Registration date

09/14/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/14/2021

Last transaction

09/14/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

11

Owner location

Rochester, NY, IE

Examiner

CANTOR, JILLIAN

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Cosmo Technologies Ltd

Representatives

John Pickerill Fredrikson & Byron, P.A.

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Contrast media for use with medical equipment or in medical imagingendoscopyx-rayultrasoundMRIPET and CT equipment; Diagnostic agents and reagents for medical use; Diagnostic preparations for medical purposes; Pharmaceutical preparations and substancesprescription medicines in the form of pillstabletscapsulescapletsliquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disordersgastrointestinal diseases or digestive system disorders; Pharmaceutical preparations for the treatment or prevention of IBS (irritable bowel syndrome); Non-prescription medicinespillstabletscapsulescapletsliquid drops for the treatment of gastrointestinal disorders; Pharmaceutical preparations for treating gastrointestinal disorders; diagnostic agentspreparations and substances for medical purposesthe visual enhancing or visualization of polypsadenomascarcinomasearly stage cancers and other lesions in the colon for patients undergoing endoscopycolonoscopysigmoidoscopyanoscopyrectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use with gastroscopicendoscopiccolonoscopicsigmoidoscopicanoscopicrectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detectiondiagnosisprevention or treatment of gastroenterological diseases; pharmaceutical preparations for use in gastroenterologyendoscopycolonoscopysigmoidoscopyanoscopyrectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceuticalmedical and surgical purposesdetectiondiagnosisprevention or treatment of gastroenterological diseases; Medical and surgical dyesmethylene blue dye; Medical dyes for pharmaceutical and diagnostic purposesthe visual enhancing or visualization of polypsadenomascarcinomasearly stage cancers and other lesions in the colon for patients undergoing endoscopycolonoscopysigmoidoscopyanoscopyrectoscopy and proctoscopy; pharmaceutical preparations for the diagnosisprevention or treatment of ulcerative colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertilityreproductive healthhematologyurologygynecologyobstetricsendocrinologyoncologyrenalologyimmunology and inflammatory diseasesdisorders and conditions; pharmaceutical preparations for colon and digestive system health and regulationfor improving energy levels or for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; Anti-nausea medication; antiemetic preparations; antibiotic preparations; pharmaceutical preparations for the treatment or prevention of travelers' diarrheadiarrheadiverticular diseasediverticulitis or infectious colitis

Class 44

Providing health care information by the internet; pharmaceutical advice; providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

38 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

09/14/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/29/2021

PUBO

PUBLISHED FOR OPPOSITION

06/29/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/09/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/27/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/11/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/11/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/07/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/19/2021

GNSL

LETTER OF SUSPENSION E-MAILED

03/19/2021

CNSL

SUSPENSION LETTER WRITTEN

03/19/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/12/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/12/2021

ALIE

ASSIGNED TO LIE

03/10/2021

NREV

NOTICE OF REVIVAL - E-MAILED

12/08/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/07/2020

PETG

PETITION TO REVIVE-GRANTED

12/07/2020

PROA

TEAS PETITION TO REVIVE RECEIVED

12/07/2020

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

12/04/2020

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

12/04/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/19/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

11/19/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/19/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/19/2020

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

11/17/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/17/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/17/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/20/2020

GNRT

NON-FINAL ACTION E-MAILED

05/20/2020

CNRT

NON-FINAL ACTION WRITTEN

05/20/2020

DOCK

ASSIGNED TO EXAMINER

05/20/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/11/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/11/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/11/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/11/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/10/2020

NWAP

NEW APPLICATION ENTERED

03/07/2020

Continuous trademark protection

Get notified about every new filing that threatens MMX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.